The evolving landscape of cancer treatment is poised for a significant shift, largely driven by the rise of "authentic" oncology drugs. This method emphasizes precision and personalized medicine, moving beyond conventional chemotherapy and broader beam therapy. Future platforms will likely integrate advanced diagnostics to identify unique genetic m